Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer

Abstract The objective of this study was to evaluate the nadir CA-125 in patients with epithelial ovarian cancer. A total of 168 patients who achieved complete remission (no clinical and radiological signs, CA-125 ≤ 35 U/ml) after first-line treatment were enrolled in the study. The relationship bet...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Szymon Piatek, Grzegorz Panek, Zbigniew Lewandowski, Dominika Piatek, Przemyslaw Kosinski, Mariusz Bidzinski
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/268c85ed85a24e249946fd10674d4b6b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!